Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Here, we report a recombinant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage XAM (Omicron BA.1.1/BA.2.9) strain that was collected in Santo Domingo, Dominican Republic. This demonstrates how SARS-CoV-2 variants can vary greatly between regions and thus underlines the great importance of regional genomic surveillance efforts.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872639PMC
http://dx.doi.org/10.1128/mra.01113-22DOI Listing

Publication Analysis

Top Keywords

sars-cov-2 lineage
8
lineage xam
8
ba11/ba29 strain
8
santo domingo
8
domingo dominican
8
dominican republic
8
genome sequence
4
sequence recombinant
4
recombinant sars-cov-2
4
xam ba11/ba29
4

Similar Publications

A Safe and Broad-spectrum SARS-CoV-2 mRNA Vaccine with a New Delivery System for In-situ Expression.

Virol Sin

September 2025

State Key Laboratory of Virology and Biosafety, RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, 430072, China; Institute for Vaccine Research at Animal Bio-safety Level Ⅲ Laboratory, Wuhan University, Wuhan, 430071, China.

Since the outbreak of SARS-CoV-2 in late 2019, the cumulative number of confirmed cases worldwide has surpassed 778 million, and the number of deaths has exceeded 7 million, posing a significant threat to human life and health while inflicting enormous losses on the global economy. At the stage where sequential immunization is recommended, there is a pressing demand for mRNA vaccines that can be rapidly adapted to new sequences, are easy to industrialize, and exhibit high safety and effectiveness. We developed a lipid nanoparticle (LNP) system, designated as WNP, which facilitates essentially in situ expression at the injection site and results in lower levels of pro-inflammatory factors in the liver, thus enhancing its safety compared to liver-targeted alternatives.

View Article and Find Full Text PDF

Genomic Diversity and Geographic Distribution of SARS-CoV-2 in Mexico: Insights From 4 Years of Genomic Surveillance.

Arch Med Res

September 2025

Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.

Background: As of September 2024, Mexico had reported over 7.6 million confirmed cases of COVID-19 and 334,785 deaths. Genomic surveillance has been essential, with 94,799 SARS-CoV-2 genomes sequenced nationwide, 38.

View Article and Find Full Text PDF

Unlabelled: Ongoing viral evolution in immunocompromised individuals with persistent infection may facilitate the evolution of SARS-CoV-2 and emergence of variants of concern (VOC). This study was conducted in the Western Cape Province of South Africa where the HIV prevalence is around 8%, with limited information on the frequency of persistent SARS-CoV-2 infection, the pattern of evolution in these individuals, and if these variants contribute to the diversity of circulating viruses. This study investigated 75 individuals with two or more SARS-CoV-2 diagnoses at least one month apart.

View Article and Find Full Text PDF

Introduction: The SARS-CoV-2 pandemic has caused a global crisis that has impacted not only health care systems, but also economies and societies. The constraints in clinical testing provide challenges in reliably assessing the prevalence of variations, particularly in regions with limited resources, testing, and sequencing capabilities. Sewage-based epidemiology uses SARS-CoV-2 in sewage as an indicator, can monitor and provide early warning of viral transmission in communities, thereby informing response strategies.

View Article and Find Full Text PDF

Viruses exhibit rapid evolutionary dynamics through random mutations and selection, driving their adaptation and cross-species transmission. To investigate these mechanisms, we designed a simulation framework with a graphical user interface (GUI), implementing random mutation and similarity-based selection. This system models the evolution of a user-supplied viral sequence toward a designated target by recursively selecting the top-N amino acid sequences with the greatest similarity in each replication cycle.

View Article and Find Full Text PDF